Mattioli Francesca, Friðriksdóttir Rún, Hebert Anne, Bassani Sissy, Ibrahim Nazia, Naz Shagufta, Chrast Jacqueline, Pailler-Pradeau Clara, Oddsson Ásmundur, Sulem Patrick, Halldorsson Gisli H, Melsted Páll, Guðbjartsson Daníel F, Palombo Flavia, Pippucci Tommaso, Nouri Nayereh, Seri Marco, Farrow Emily G, Saunders Carol J, Guex Nicolas, Ansar Muhammad, Stefansson Kari, Reymond Alexandre
Center for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
deCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Genome Med. 2025 Apr 14;17(1):38. doi: 10.1186/s13073-025-01463-3.
Variants in genes encoding multiple subunits of the RNA Polymerase III complex which synthesizes rRNAs, tRNAs, and other small RNAs were previously associated with neurological disorders, such as syndromic hypomyelination leukodystrophies, pontocerebellar hypoplasia, and cerebellofaciodental syndrome. One new such candidate is BRF2, which encodes a TFIIB-like factor that recruits the RNA polymerase III complex to type 3 promoters to initiate transcription of U6, RnaseP, and 7SK RNAs.
We combined sequencing with functional analyses to investigate the effects of BRF2 variants.
We observe that a previously reported significant underrepresentation of double transmission of a splice variant results in recessive lethality in three large Icelandic families with multiple perinatal losses. Using data aggregation, we identified an additional seven individuals worldwide from three unrelated families carrying biallelic variants in BRF2. Affected individuals present a variable phenotype ranging from severe craniofacial anomalies with early death to intellectual disability with motor and speech development. In silico 3D modelling and functional analyses showed functional impairment of the identified variants, e.g., differences in target loci occupancy. Zebrafish knocked down for the orthologous brf2 presented with abnormal escape response, reduced swimming velocity and head size, and craniofacial malformations. These defects were complemented by the human wild-type but not mutated BRF2 mRNA further demonstrating their deleteriousness.
Overall, our results support the association of biallelic BRF2 variants with a novel neurodevelopmental disease and provide an additional link between RNA polymerase III, its targets and craniofacial anomalies.
编码参与合成rRNA、tRNA和其他小RNA的RNA聚合酶III复合物多个亚基的基因变异,先前与神经系统疾病有关,如综合征性髓鞘形成低下性脑白质营养不良、脑桥小脑发育不全和小脑面牙综合征。一个新的此类候选基因是BRF2,它编码一种TFIIB样因子,该因子将RNA聚合酶III复合物募集到3型启动子上,以启动U6、RnaseP和7SK RNA的转录。
我们将测序与功能分析相结合,以研究BRF2变异的影响。
我们观察到,先前报道的一种剪接变异的双传递显著不足,导致三个有多次围产期死亡的大型冰岛家庭出现隐性致死。通过数据汇总,我们在全球范围内从三个不相关的家庭中又鉴定出另外七个携带BRF2双等位基因变异的个体。受影响个体表现出可变的表型,从伴有早期死亡的严重颅面畸形到伴有运动和语言发育的智力残疾。计算机三维建模和功能分析显示,所鉴定的变异存在功能损害,例如靶位点占据的差异。敲低直系同源brf2的斑马鱼表现出异常的逃避反应、游泳速度和头部大小降低以及颅面畸形。这些缺陷可由人类野生型而非突变型BRF2 mRNA互补,进一步证明了它们的有害性。
总体而言,我们的结果支持双等位基因BRF2变异与一种新型神经发育疾病的关联,并提供了RNA聚合酶III及其靶标与颅面畸形之间的另一个联系。